Cargando…

Diagnostic Value of Dynamic Enhanced Magnetic Resonance Imaging Combined with Serum CA15-3, CYFRA21-1, and TFF1 for Breast Cancer

OBJECTIVE: To explore the diagnostic value of dynamic enhanced magnetic resonance imaging (MRI) combined with serum CA15-3, CYFRA21-1, and TFF1 for breast cancer. METHODS: By means of a retrospective study, 60 breast cancer patients treated in our hospital from January 2018 to December 2020 were sel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Feng, Meng, Yu, Jiang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983227/ https://www.ncbi.nlm.nih.gov/pubmed/35392152 http://dx.doi.org/10.1155/2022/7984591

Ejemplares similares

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
por: Zhang, Zhen, et al.
Publicado: (2017)

Diagnostic value of CA‐153 and CYFRA 21‐1 in predicting intraocular metastasis in patients with metastatic lung cancer
por: Lin, Qi, et al.
Publicado: (2019)

Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
por: Hyun, Jae-Won, et al.
Publicado: (2017)

Elevated serum CYFRA 21‐1 level as a diagnostic marker for thymic carcinoma
por: Shiiya, Haruhiko, et al.
Publicado: (2021)

Clinical significance of serum CYFRA 21-1 in gastric cancer.
por: Nakata, B., et al.
Publicado: (1996)

CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
por: Gjavotchanoff, Risto
Publicado: (2015)

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
por: Weber, Daniel Gilbert, et al.
Publicado: (2010)

Diagnostic and Prognostic Significance of Serum Biomarkers – Serum Amyloid A and CYFRA 21-1 in Lung Cancer
por: Dhanurdhar, Yera, et al.
Publicado: (2023)

Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma
por: Yuan, Chuanshu, et al.
Publicado: (2016)

Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer
por: Zhang, Zhi-Hui, et al.
Publicado: (2015)

Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer
por: Qu, Tao, et al.
Publicado: (2019)

Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: Shang, Liqun, et al.
Publicado: (2021)

Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125
por: Jin, Chunjing, et al.
Publicado: (2019)

Retracted: Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Evaluation of serum cyfra21 in patients with pleural effusion
por: Azimi, Q, et al.
Publicado: (2012)

CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases.
por: Tempfer, C., et al.
Publicado: (1998)

Increases in Serum CYFRA21-1 Concentration during Successful Treatment with Crizotinib
por: Kanaji, Nobuhiro, et al.
Publicado: (2014)

Role of Serum CYFRA 21-1 in Diagnosis and Prognostic in Colorectal Liver Metastases
por: Li, Shirong, et al.
Publicado: (2023)

CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
por: Garcia-Valdecasas Gayo, Sonsoles, et al.
Publicado: (2020)

CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis
por: Li, Biao, et al.
Publicado: (2020)

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
por: Thomas, D S, et al.
Publicado: (2015)

Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
por: Xu, Youtao, et al.
Publicado: (2015)

Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer
por: Ishibashi, Yuko, et al.
Publicado: (2017)

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy
por: Gauthé, Mathieu, et al.
Publicado: (2018)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
por: Uenishi, T, et al.
Publicado: (2003)

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma
por: Hsu, Yin-Ping, et al.
Publicado: (2015)

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Serum CYFRA 21-1 but not Vimentin is Associated with Poor Prognosis in Advanced Lung Cancer Patients
por: Kanaji, Nobuhiro, et al.
Publicado: (2019)

Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
por: Jeong, Chaiho, et al.
Publicado: (2021)

Estimation of salivary and serum CYFRA 21-1 levels in patients with oral squamous cell carcinoma
por: Adusumilli, Praveena, et al.
Publicado: (2023)

Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
por: Ju, Mengyang, et al.
Publicado: (2022)

High serum levels of CA 19-9 and CYFRA21-1 caused by renal pelvis urothelial carcinoma: a report of two cases
por: Yin, Guolin, et al.
Publicado: (2021)

Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion
por: Xu, Zhiyang, et al.
Publicado: (2022)

The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
por: Fujimoto, Hajime, et al.
Publicado: (2022)

Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR
por: Li, Tao, et al.
Publicado: (2023)

Diagnostic accuracy and prognostic applications of CYFRA 21-1 in head and neck cancer: A systematic review and meta-analysis
por: Liu, Lihui, et al.
Publicado: (2019)

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study
por: Ono, Akira, et al.
Publicado: (2013)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
por: Kim, Young-Chul, et al.
Publicado: (1996)

AB010. Clinical significance of serum Cyfra 21-1 as a marker in thymic epithelial tumors
por: Hao, Xiuxiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e33givff5ptviogfd1snho38fv